^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    bb21217

    i
    Other names: bb21217, Next gen anti-BCMA CAR T-cells
    Company:
    BMS, Regeneron
    Drug class:
    BCMA-targeted CAR-T immunotherapy
    Related drugs: